COVID-19 Impact on Global Antibody Humanization Market Size, Status and Forecast 2020-2026

September 2020 | 91 pages | ID: C8EF94484667EN
QYResearch

Abstracts

This report focuses on the global Antibody Humanization status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antibody Humanization development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Accurus Biosciences
• IONTAS
• Lonza
• Oak BioSciences
• Panorama Research
• PX'Therapeutics
• Yurogen Biosystems

Market segment by Type, the product can be split into

• Monoclonal Antibodies
• Bispecific Antibodies
• CDR Grafted Antibodies

Market segment by Application, split into

• HIV
• SARS
• RSV
• Prion

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Antibody Humanization status, future forecast, growth opportunity, key market and key players.
• To present the Antibody Humanization development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Antibody Humanization are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antibody Humanization Revenue
1.4 Market Analysis by Type
  1.4.1 Global Antibody Humanization Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Monoclonal Antibodies
  1.4.3 Bispecific Antibodies
  1.4.4 CDR Grafted Antibodies
1.5 Market by Application
  1.5.1 Global Antibody Humanization Market Share by Application: 2020 VS 2026
  1.5.2 HIV
  1.5.3 SARS
  1.5.4 RSV
  1.5.5 Prion
1.6 Coronavirus Disease 2019 (Covid-19): Antibody Humanization Industry Impact
  1.6.1 How the Covid-19 is Affecting the Antibody Humanization Industry
    1.6.1.1 Antibody Humanization Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Antibody Humanization Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Antibody Humanization Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Antibody Humanization Market Perspective (2015-2026)
2.2 Antibody Humanization Growth Trends by Regions
  2.2.1 Antibody Humanization Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antibody Humanization Historic Market Share by Regions (2015-2020)
  2.2.3 Antibody Humanization Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Antibody Humanization Market Growth Strategy
  2.3.6 Primary Interviews with Key Antibody Humanization Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antibody Humanization Players by Market Size
  3.1.1 Global Top Antibody Humanization Players by Revenue (2015-2020)
  3.1.2 Global Antibody Humanization Revenue Market Share by Players (2015-2020)
  3.1.3 Global Antibody Humanization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antibody Humanization Market Concentration Ratio
  3.2.1 Global Antibody Humanization Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Antibody Humanization Revenue in 2019
3.3 Antibody Humanization Key Players Head office and Area Served
3.4 Key Players Antibody Humanization Product Solution and Service
3.5 Date of Enter into Antibody Humanization Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Antibody Humanization Historic Market Size by Type (2015-2020)
4.2 Global Antibody Humanization Forecasted Market Size by Type (2021-2026)

5 ANTIBODY HUMANIZATION BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Antibody Humanization Market Size by Application (2015-2020)
5.2 Global Antibody Humanization Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antibody Humanization Market Size (2015-2020)
6.2 Antibody Humanization Key Players in North America (2019-2020)
6.3 North America Antibody Humanization Market Size by Type (2015-2020)
6.4 North America Antibody Humanization Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Antibody Humanization Market Size (2015-2020)
7.2 Antibody Humanization Key Players in Europe (2019-2020)
7.3 Europe Antibody Humanization Market Size by Type (2015-2020)
7.4 Europe Antibody Humanization Market Size by Application (2015-2020)

8 CHINA

8.1 China Antibody Humanization Market Size (2015-2020)
8.2 Antibody Humanization Key Players in China (2019-2020)
8.3 China Antibody Humanization Market Size by Type (2015-2020)
8.4 China Antibody Humanization Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Antibody Humanization Market Size (2015-2020)
9.2 Antibody Humanization Key Players in Japan (2019-2020)
9.3 Japan Antibody Humanization Market Size by Type (2015-2020)
9.4 Japan Antibody Humanization Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Antibody Humanization Market Size (2015-2020)
10.2 Antibody Humanization Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antibody Humanization Market Size by Type (2015-2020)
10.4 Southeast Asia Antibody Humanization Market Size by Application (2015-2020)

11 INDIA

11.1 India Antibody Humanization Market Size (2015-2020)
11.2 Antibody Humanization Key Players in India (2019-2020)
11.3 India Antibody Humanization Market Size by Type (2015-2020)
11.4 India Antibody Humanization Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Antibody Humanization Market Size (2015-2020)
12.2 Antibody Humanization Key Players in Central & South America (2019-2020)
12.3 Central & South America Antibody Humanization Market Size by Type (2015-2020)
12.4 Central & South America Antibody Humanization Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Accurus Biosciences
  13.1.1 Accurus Biosciences Company Details
  13.1.2 Accurus Biosciences Business Overview and Its Total Revenue
  13.1.3 Accurus Biosciences Antibody Humanization Introduction
  13.1.4 Accurus Biosciences Revenue in Antibody Humanization Business (2015-2020))
  13.1.5 Accurus Biosciences Recent Development
13.2 IONTAS
  13.2.1 IONTAS Company Details
  13.2.2 IONTAS Business Overview and Its Total Revenue
  13.2.3 IONTAS Antibody Humanization Introduction
  13.2.4 IONTAS Revenue in Antibody Humanization Business (2015-2020)
  13.2.5 IONTAS Recent Development
13.3 Lonza
  13.3.1 Lonza Company Details
  13.3.2 Lonza Business Overview and Its Total Revenue
  13.3.3 Lonza Antibody Humanization Introduction
  13.3.4 Lonza Revenue in Antibody Humanization Business (2015-2020)
  13.3.5 Lonza Recent Development
13.4 Oak BioSciences
  13.4.1 Oak BioSciences Company Details
  13.4.2 Oak BioSciences Business Overview and Its Total Revenue
  13.4.3 Oak BioSciences Antibody Humanization Introduction
  13.4.4 Oak BioSciences Revenue in Antibody Humanization Business (2015-2020)
  13.4.5 Oak BioSciences Recent Development
13.5 Panorama Research
  13.5.1 Panorama Research Company Details
  13.5.2 Panorama Research Business Overview and Its Total Revenue
  13.5.3 Panorama Research Antibody Humanization Introduction
  13.5.4 Panorama Research Revenue in Antibody Humanization Business (2015-2020)
  13.5.5 Panorama Research Recent Development
13.6 PX'Therapeutics
  13.6.1 PX'Therapeutics Company Details
  13.6.2 PX'Therapeutics Business Overview and Its Total Revenue
  13.6.3 PX'Therapeutics Antibody Humanization Introduction
  13.6.4 PX'Therapeutics Revenue in Antibody Humanization Business (2015-2020)
  13.6.5 PX'Therapeutics Recent Development
13.7 Yurogen Biosystems
  13.7.1 Yurogen Biosystems Company Details
  13.7.2 Yurogen Biosystems Business Overview and Its Total Revenue
  13.7.3 Yurogen Biosystems Antibody Humanization Introduction
  13.7.4 Yurogen Biosystems Revenue in Antibody Humanization Business (2015-2020)
  13.7.5 Yurogen Biosystems Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Antibody Humanization Key Market Segments
Table 2. Key Players Covered: Ranking by Antibody Humanization Revenue
Table 3. Ranking of Global Top Antibody Humanization Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antibody Humanization Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Bispecific Antibodies
Table 7. Key Players of CDR Grafted Antibodies
Table 8. COVID-19 Impact Global Market: (Four Antibody Humanization Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Antibody Humanization Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Antibody Humanization Players to Combat Covid-19 Impact
Table 13. Global Antibody Humanization Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Antibody Humanization Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Antibody Humanization Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Antibody Humanization Market Share by Regions (2015-2020)
Table 17. Global Antibody Humanization Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Antibody Humanization Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Antibody Humanization Market Growth Strategy
Table 23. Main Points Interviewed from Key Antibody Humanization Players
Table 24. Global Antibody Humanization Revenue by Players (2015-2020) (Million US$)
Table 25. Global Antibody Humanization Market Share by Players (2015-2020)
Table 26. Global Top Antibody Humanization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Humanization as of 2019)
Table 27. Global Antibody Humanization by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Antibody Humanization Product Solution and Service
Table 30. Date of Enter into Antibody Humanization Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Antibody Humanization Market Size by Type (2015-2020) (Million US$)
Table 33. Global Antibody Humanization Market Size Share by Type (2015-2020)
Table 34. Global Antibody Humanization Revenue Market Share by Type (2021-2026)
Table 35. Global Antibody Humanization Market Size Share by Application (2015-2020)
Table 36. Global Antibody Humanization Market Size by Application (2015-2020) (Million US$)
Table 37. Global Antibody Humanization Market Size Share by Application (2021-2026)
Table 38. North America Key Players Antibody Humanization Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Antibody Humanization Market Share (2019-2020)
Table 40. North America Antibody Humanization Market Size by Type (2015-2020) (Million US$)
Table 41. North America Antibody Humanization Market Share by Type (2015-2020)
Table 42. North America Antibody Humanization Market Size by Application (2015-2020) (Million US$)
Table 43. North America Antibody Humanization Market Share by Application (2015-2020)
Table 44. Europe Key Players Antibody Humanization Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Antibody Humanization Market Share (2019-2020)
Table 46. Europe Antibody Humanization Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Antibody Humanization Market Share by Type (2015-2020)
Table 48. Europe Antibody Humanization Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Antibody Humanization Market Share by Application (2015-2020)
Table 50. China Key Players Antibody Humanization Revenue (2019-2020) (Million US$)
Table 51. China Key Players Antibody Humanization Market Share (2019-2020)
Table 52. China Antibody Humanization Market Size by Type (2015-2020) (Million US$)
Table 53. China Antibody Humanization Market Share by Type (2015-2020)
Table 54. China Antibody Humanization Market Size by Application (2015-2020) (Million US$)
Table 55. China Antibody Humanization Market Share by Application (2015-2020)
Table 56. Japan Key Players Antibody Humanization Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Antibody Humanization Market Share (2019-2020)
Table 58. Japan Antibody Humanization Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Antibody Humanization Market Share by Type (2015-2020)
Table 60. Japan Antibody Humanization Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Antibody Humanization Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Antibody Humanization Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Antibody Humanization Market Share (2019-2020)
Table 64. Southeast Asia Antibody Humanization Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Antibody Humanization Market Share by Type (2015-2020)
Table 66. Southeast Asia Antibody Humanization Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Antibody Humanization Market Share by Application (2015-2020)
Table 68. India Key Players Antibody Humanization Revenue (2019-2020) (Million US$)
Table 69. India Key Players Antibody Humanization Market Share (2019-2020)
Table 70. India Antibody Humanization Market Size by Type (2015-2020) (Million US$)
Table 71. India Antibody Humanization Market Share by Type (2015-2020)
Table 72. India Antibody Humanization Market Size by Application (2015-2020) (Million US$)
Table 73. India Antibody Humanization Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Antibody Humanization Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Antibody Humanization Market Share (2019-2020)
Table 76. Central & South America Antibody Humanization Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Antibody Humanization Market Share by Type (2015-2020)
Table 78. Central & South America Antibody Humanization Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Antibody Humanization Market Share by Application (2015-2020)
Table 80. Accurus Biosciences Company Details
Table 81. Accurus Biosciences Business Overview
Table 82. Accurus Biosciences Product
Table 83. Accurus Biosciences Revenue in Antibody Humanization Business (2015-2020) (Million US$)
Table 84. Accurus Biosciences Recent Development
Table 85. IONTAS Company Details
Table 86. IONTAS Business Overview
Table 87. IONTAS Product
Table 88. IONTAS Revenue in Antibody Humanization Business (2015-2020) (Million US$)
Table 89. IONTAS Recent Development
Table 90. Lonza Company Details
Table 91. Lonza Business Overview
Table 92. Lonza Product
Table 93. Lonza Revenue in Antibody Humanization Business (2015-2020) (Million US$)
Table 94. Lonza Recent Development
Table 95. Oak BioSciences Company Details
Table 96. Oak BioSciences Business Overview
Table 97. Oak BioSciences Product
Table 98. Oak BioSciences Revenue in Antibody Humanization Business (2015-2020) (Million US$)
Table 99. Oak BioSciences Recent Development
Table 100. Panorama Research Company Details
Table 101. Panorama Research Business Overview
Table 102. Panorama Research Product
Table 103. Panorama Research Revenue in Antibody Humanization Business (2015-2020) (Million US$)
Table 104. Panorama Research Recent Development
Table 105. PX'Therapeutics Company Details
Table 106. PX'Therapeutics Business Overview
Table 107. PX'Therapeutics Product
Table 108. PX'Therapeutics Revenue in Antibody Humanization Business (2015-2020) (Million US$)
Table 109. PX'Therapeutics Recent Development
Table 110. Yurogen Biosystems Company Details
Table 111. Yurogen Biosystems Business Overview
Table 112. Yurogen Biosystems Product
Table 113. Yurogen Biosystems Revenue in Antibody Humanization Business (2015-2020) (Million US$)
Table 114. Yurogen Biosystems Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Antibody Humanization Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Bispecific Antibodies Features
Figure 4. CDR Grafted Antibodies Features
Figure 5. Global Antibody Humanization Market Share by Application: 2020 VS 2026
Figure 6. HIV Case Studies
Figure 7. SARS Case Studies
Figure 8. RSV Case Studies
Figure 9. Prion Case Studies
Figure 10. Antibody Humanization Report Years Considered
Figure 11. Global Antibody Humanization Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Antibody Humanization Market Share by Regions: 2020 VS 2026
Figure 13. Global Antibody Humanization Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Antibody Humanization Market Share by Players in 2019
Figure 16. Global Top Antibody Humanization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Humanization as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Antibody Humanization Revenue in 2019
Figure 18. North America Antibody Humanization Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Antibody Humanization Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Antibody Humanization Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Antibody Humanization Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Antibody Humanization Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Antibody Humanization Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Antibody Humanization Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Accurus Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Accurus Biosciences Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 27. IONTAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. IONTAS Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 29. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Lonza Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 31. Oak BioSciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Oak BioSciences Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 33. Panorama Research Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Panorama Research Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 35. PX'Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. PX'Therapeutics Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 37. Yurogen Biosystems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Yurogen Biosystems Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed